G. Bellon

4.8k total citations · 2 hit papers
96 papers, 3.3k citations indexed

About

G. Bellon is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, G. Bellon has authored 96 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Pulmonary and Respiratory Medicine, 18 papers in Surgery and 14 papers in Epidemiology. Recurrent topics in G. Bellon's work include Cystic Fibrosis Research Advances (48 papers), Neonatal Respiratory Health Research (22 papers) and Tracheal and airway disorders (17 papers). G. Bellon is often cited by papers focused on Cystic Fibrosis Research Advances (48 papers), Neonatal Respiratory Health Research (22 papers) and Tracheal and airway disorders (17 papers). G. Bellon collaborates with scholars based in France, Germany and United States. G. Bellon's co-authors include Gerd Döring, Martina Ulrich, Jürgen Berger, Dieter Worlitzsch, Robert Tarran, Keith C. Meyer, Scott H. Randell, Tilo Weiß, K Botzenhart and Richard C. Boucher and has published in prestigious journals such as Journal of Clinical Investigation, American Journal of Clinical Nutrition and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

G. Bellon

91 papers receiving 3.3k citations

Hit Papers

Effects of reduced mucus oxygen concentration in airway P... 2002 2026 2010 2018 2002 2002 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Bellon France 24 2.1k 1.3k 405 371 279 96 3.3k
Martin Walshaw United Kingdom 35 2.1k 1.0× 1.4k 1.1× 791 2.0× 396 1.1× 258 0.9× 122 3.6k
Manu Jain United States 31 1.5k 0.7× 1.4k 1.0× 441 1.1× 377 1.0× 238 0.9× 95 3.5k
Nicole Mayer-Hamblett United States 39 4.1k 1.9× 997 0.8× 513 1.3× 901 2.4× 183 0.7× 105 5.3k
S.P. Conway United Kingdom 35 2.8k 1.3× 515 0.4× 515 1.3× 774 2.1× 170 0.6× 90 3.9k
H. von der Hardt Germany 30 2.0k 1.0× 606 0.5× 353 0.9× 320 0.9× 152 0.5× 98 2.8k
Sharon McNamara United States 30 3.4k 1.6× 1.6k 1.2× 615 1.5× 865 2.3× 233 0.8× 64 4.9k
Tacjana Pressler Denmark 35 2.6k 1.2× 1.8k 1.4× 834 2.1× 710 1.9× 570 2.0× 117 4.6k
Andrew Jones United Kingdom 33 2.1k 1.0× 595 0.5× 262 0.6× 601 1.6× 271 1.0× 159 3.2k
Damien Roux France 27 721 0.3× 954 0.7× 465 1.1× 467 1.3× 290 1.0× 91 2.8k
Emily DiMango United States 27 1.8k 0.9× 829 0.6× 220 0.5× 210 0.6× 143 0.5× 70 3.3k

Countries citing papers authored by G. Bellon

Since Specialization
Citations

This map shows the geographic impact of G. Bellon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Bellon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Bellon more than expected).

Fields of papers citing papers by G. Bellon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Bellon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Bellon. The network helps show where G. Bellon may publish in the future.

Co-authorship network of co-authors of G. Bellon

This figure shows the co-authorship network connecting the top 25 collaborators of G. Bellon. A scholar is included among the top collaborators of G. Bellon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Bellon. G. Bellon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Munck, À., et al.. (2020). Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening. Pediatric Pulmonology. 55(4). 918–928. 42 indexed citations
2.
Fayon, Michaël, Harriet Corvol, R. Chiron, et al.. (2013). Consensus national sur les modalités de prescription des corticoïdes inhalés dans la mucoviscidose. Archives de Pédiatrie. 21(1). 88–94. 2 indexed citations
4.
Bilton, Diana, Moira L. Aitken, Patrick A. Flume, et al.. (2011). 78 Combined data from two phase III studies of Bronchitol (inhaled dry powder mannitol) in adult cystic fibrosis (CF) patients. Journal of Cystic Fibrosis. 10. S20–S20. 2 indexed citations
5.
Aitken, Moira L., G. Bellon, K. De Boeck, et al.. (2011). Long-Term Inhaled Dry Powder Mannitol in Cystic Fibrosis: An International Randomized Study. American Journal of Respiratory and Critical Care Medicine. 185(6). 645–652. 94 indexed citations
6.
Dubois, R., et al.. (2010). Atteinte granulomateuse pulmonaire précédant le diagnostic de maladie de Crohn : à propos d’un cas pédiatrique. Archives de Pédiatrie. 17(9). 1308–1312. 4 indexed citations
7.
Reix, Philippe, G. Bellon, & P. Braillon. (2009). Bone mineral and body composition alterations in paediatric cystic fibrosis patients. Pediatric Radiology. 40(3). 301–308. 14 indexed citations
8.
Tournoud, Maud, René Écochard, Jean Iwaz, et al.. (2008). Structural equations to model relationships between pulmonary function, fatty acids and oxidation in cystic fibrosis. Scandinavian Journal of Clinical and Laboratory Investigation. 69(1). 36–44. 2 indexed citations
9.
Jaubert, Francis, Rola Abou Taam, Louise Galmiche, et al.. (2008). Diffuse Lymphoplasmacytic Bronchiolitis in Cartilage-Hair Hypoplasia. The Journal of Pediatrics. 152(3). 429–433.e1. 6 indexed citations
10.
Munck, À., Thierry Lamireau, B. Le Luyer, et al.. (2008). Pancreatic enzyme replacement therapy for young cystic fibrosis patients. Journal of Cystic Fibrosis. 8(1). 14–18. 31 indexed citations
11.
Durieu, I., Evelyne Véricel, Hubert Roth, et al.. (2007). Fatty acids platelets and oxidative markers following intravenous n-3 fatty acids administration in cystic fibrosis: An open pilot observational study. Journal of Cystic Fibrosis. 6(5). 320–326. 17 indexed citations
12.
Louis, Dominique, et al.. (2007). Partial splenectomy for portal hypertension in cystic fibrosis related liver disease. Pediatric Pulmonology. 42(12). 1173–1180. 21 indexed citations
13.
Reix, Philippe, et al.. (2006). Session : Interrelations entre pathologies ORL et bronchopulmonaireDyskinésie ciliaire, aspects bronchopulmonairesCiliary dyskinesia, bronchopulmonary manifestations. Archives de Pédiatrie. 13(6). 1 indexed citations
15.
Mély, Laurent, et al.. (2004). Agénésie isolée de l'artère pulmonaire. À propos de huit observations. Archives de Pédiatrie. 11(9). 1078–1082. 5 indexed citations
16.
Worlitzsch, Dieter, Robert Tarran, Martina Ulrich, et al.. (2002). Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. Journal of Clinical Investigation. 109(3). 317–325. 778 indexed citations breakdown →
17.
Worlitzsch, Dieter, Robert Tarran, Martina Ulrich, et al.. (2002). Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. Journal of Clinical Investigation. 109(3). 317–325. 919 indexed citations breakdown →
18.
Bellon, G.. (2001). Bronchiolite aiguë du nourrisson. Définition. Archives de Pédiatrie. 8. 25–30. 5 indexed citations
19.
Durieu, I., et al.. (1998). Subepithelial Fibrosis and Degradation of the Bronchial Extracellular Matrix in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 158(2). 580–588. 50 indexed citations
20.
Giudicelli, J. F., et al.. (1994). Syndrome de Destombes-Rosai-Dorfman : deux formes cliniques inhabituelles. La Revue de Médecine Interne. 15(12). 834–837. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026